Replies to post #674 on Rezolute Inc. (RZLT)

[Whalatane]

The less positive view on RZLT
Stephen Ayers

To clarify, I am not necessarily "bearish" on P3 outcomes in December. I think it's 50/50. No real alpha there. I just think the regulatory/commercial opportunity is overstated. So, the best alpha would be shorting after a P3 "win." I'm assuming stock would be valued at ~$2B in that event.

.

Important to consider all sides
I'll definitely sell at least some on a positive trial result
JMO
Kiwi